Visual loss is one of the most common clinical manifestations of multiple sclerosis (MS). Quantitative assessment of visual impairment in MS trials, however, has been limited to Snellen acuity. The longitudinal visual profile of MS, using sensitive yet clinically practical visual function measures, has not been defined. The extent to which vision is affected over time by immunomodulatory therapies is also not known, and has been difficult to assess using traditional scales of neurologic impairment, such as the Expanded Disability Status Scale (EDSS). Even the MS Functional Composite (MSFC), the newest clinical outcome measure for MS trials, does not yet include an assessment of visual function. Our preliminary data from an ongoing cross-sectional study of visual function in MS at the University of Pennsylvania provide strong evidence that, among 5 candidate vision tests, contrast letter acuity and contrast sensitivity best distinguish MS patients from disease-free controls, even following detailed refractions and analyses accounting for age. The capacity for visual function tests to predict changes in MS disease longitudinally, however, has not been examined in clinically heterogeneous cohorts. This proposal will accomplish three specific aims:
Aim 1 : Define the longitudinal visual profile of MS in a large cohort, and determine which visual function tests demonstrate the greatest degree responsiveness to change over time.
Aim 2 : Determine the relation of baseline visual function test scores to subsequent neurologic impairment, and the relation between changes in visual function and changes in neurologic impairment over time, as measured by the EDSS and MSFC.
Aim 3 : Examine the relation of baseline visual function test scores to health-related quality of life (HRQOL) at subsequent study visits, and the relation between changes in visual function and changes in HRQOL over time, as measured by the 25-Item National Eye Institute Visual Function Questionnaire (VFQ-25) and the Multiple Sclerosis Quality of Life Inventory (MSQLI). Collectively, these aims will lead to the identification of sensitive, valid, and clinically practical visual function tests that are responsive to changes in MS disease over time, and will be capable of capturing treatment effects in future trials of MS therapies.

Agency
National Institute of Health (NIH)
Institute
National Eye Institute (NEI)
Type
Research Project (R01)
Project #
5R01EY014993-02
Application #
6793164
Study Section
Special Emphasis Panel (ZEY1-VSN (02))
Program Officer
Kurinij, Natalie
Project Start
2003-09-01
Project End
2008-08-31
Budget Start
2004-09-24
Budget End
2005-08-31
Support Year
2
Fiscal Year
2004
Total Cost
$127,291
Indirect Cost
Name
University of Pennsylvania
Department
Neurology
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Meltzer, Ethan; Sguigna, Peter V; Subei, Adnan et al. (2017) Retinal Architecture and Melanopsin-Mediated Pupillary Response Characteristics: A Putative Pathophysiologic Signature for the Retino-Hypothalamic Tract in Multiple Sclerosis. JAMA Neurol 74:574-582
Al-Louzi, Omar A; Bhargava, Pavan; Newsome, Scott D et al. (2016) Outer retinal changes following acute optic neuritis. Mult Scler 22:362-72
Fielding, Joanne; Clough, Meaghan; Beh, Shin et al. (2015) Ocular motor signatures of cognitive dysfunction in multiple sclerosis. Nat Rev Neurol 11:637-45
Saidha, Shiv; Al-Louzi, Omar; Ratchford, John N et al. (2015) Optical coherence tomography reflects brain atrophy in multiple sclerosis: A four-year study. Ann Neurol 78:801-13
Schnurman, Zane S; Frohman, Teresa C; Beh, Shin C et al. (2014) Retinal architecture and mfERG: Optic nerve head component response characteristics in MS. Neurology 82:1888-96
Frohman, Teresa C; Davis, Scott L; Beh, Shin et al. (2013) Uhthoff's phenomena in MS--clinical features and pathophysiology. Nat Rev Neurol 9:535-40
Ratchford, John N; Saidha, Shiv; Sotirchos, Elias S et al. (2013) Active MS is associated with accelerated retinal ganglion cell/inner plexiform layer thinning. Neurology 80:47-54
Sotirchos, Elias S; Saidha, Shiv; Byraiah, Gita et al. (2013) In vivo identification of morphologic retinal abnormalities in neuromyelitis optica. Neurology 80:1406-14
Walter, Scott D; Ishikawa, Hiroshi; Galetta, Kristin M et al. (2012) Ganglion cell loss in relation to visual disability in multiple sclerosis. Ophthalmology 119:1250-7
Blazek, Paul; Davis, Scott L; Greenberg, Benjamin M et al. (2012) Objective characterization of the relative afferent pupillary defect in MS. J Neurol Sci 323:193-200

Showing the most recent 10 out of 20 publications